Novartis Gets Expert Testimony Blocked In Aredia-Zometa MDL

Law360, New York (December 17, 2012, 5:02 PM EST) -- A Tennessee federal judge on Thursday barred portions of expert testimony in cases stemming from multidistrict litigation against Novartis Pharmaceuticals Corp. over jaw damage blamed on osteoporosis drugs Aredia and Zometa, calling the witness unqualified to speak about links between the medications and bone loss.

U.S. Magistrate Judge C. Clifford Shirley Jr. partially granted a motion to exclude testimony after concluding that while Dr. Suzanne Parisian holds a medical degree, her career has been overwhelmingly focused on regulatory matters, not the actual practice of medicine. In...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Jenkins v. Novartis Pharmaceuticals Corporation


Case Number

3:11-cv-00342

Court

Tennessee Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Tena Campbell

Date Filed

July 20, 2011


Case Title

Thorn v. Novartis Pharmaceuticals Corporation (PLR1)


Case Number

3:11-cv-00373

Court

Tennessee Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Pamela L Reeves

Date Filed

August 11, 2011

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.